Nicotinic Acetylcholine Receptor-Mediated [3H]Dopamine Release from Hippocampus
- 1 March 2005
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 312 (3) , 1298-1304
- https://doi.org/10.1124/jpet.104.076794
Abstract
The mechanism of nicotinic acetylcholine receptor (nAChR)-induced hippocampal dopamine (DA) release was investigated using rat hippocampal slices. nAChRs involved in hippocampal DA and norepinephrine (NE) release were investigated using prototypical agonists and antagonists and several relatively novel compounds: ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine], (±)-UB-165 [(2-chloro-5-pyridyl)-9-azabicyclo [4.2.1]non2-ene], and MG 624 [N,N,N-triethyl-2-[4-(2 phenylethenyl)phenoxy]-ethanaminium iodine]. (±)-Epibatidine, (±)-UB-165, anatoxin-a, ABT-594, (-)-nicotine, 1,1-dimethyl-4-phenyl-piperazinium iodide, and (-)-cytisine (in decreasing order of potency) evoked [3H]DA release in a mecamylamine-sensitive manner. Aside from (±)-UB-165, all the agonists displayed full efficacy relative to 100 μM (-)-nicotine in [3H]DA release. In contrast, (±)-UB-165 was a partial agonist, evoking 58% of 100 μM (-)-nicotine response. Mecamylamine, MG 624, hexamethonium, d-tubocurare, and dihydro-β-erythroidine (in decreasing order of potency), but not α-conotoxin-MII, methyllycaconitine, α-conotoxin-ImI, or α-bungarotoxin, attenuated 100 μM (-)-nicotine-evoked [3H]DA release in a concentration-dependent manner. (±)-UB-165, ABT-594, and MG 624 exhibited different pharmacologic profiles in the [3H]NE release assay when compared with their effect on [3H]DA release. ABT-594 was 4.5-fold more potent, and (±)-UB-165 was a full agonist in contrast to its partial agonism in [3H]DA release. MG 624 potently and completely blocked NE release evoked by 100 μM (-)-nicotine and 10 μM (±)-UB-165, whereas it only partially inhibited (-)-nicotine-evoked [3H]DA release. In conclusion, we provide evidence that [3H]DA can be evoked from the hippocampus and that the pharmacologic profile for nAChR-evoked hippocampal [3H]DA release suggests the involvement of α3β4* and at least one other nAChR subtype, thus distinguishing it from that of nAChR-evoked hippocampal [3H]NE release.Keywords
This publication has 34 references indexed in Scilit:
- Cholinergic nicotinic receptors: Competitive ligands, allosteric modulators, and their potential applicationsMedicinal Research Reviews, 2003
- Cognitive Enhancing Properties and Tolerability of Cholinergic Agents in Mice: A Comparative Study of Nicotine, Donepezil, and SIB-1553A, a Subtype-Selective Ligand for Nicotinic Acetylcholine ReceptorsNeuropsychopharmacology, 2003
- Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neuronsJournal of Comparative Neurology, 2002
- Selective effects of a 4‐oxystilbene derivative on wild and mutant neuronal chick α7 nicotinic receptorBritish Journal of Pharmacology, 1999
- Functional contribution of the α5 subunit to neuronal nicotinic channels expressed by chick sympathetic ganglion neuronesThe Journal of Physiology, 1998
- Evidence for Nicotinic Receptors Potentially Modulating Nociceptive Transmission at the Level of the Primary Sensory Neuron: Studies with F11 CellsJournal of Neurochemistry, 1997
- Presynaptic nicotinic ACh receptorsPublished by Elsevier ,1997
- Autoradiographic localization of dopamine uptake sites in the rat brain with3H-GBR 12935Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- Nicotinic Modulation of [3H]Dopamine Release from Striatal Synaptosomes: Pharmacological CharacterisationJournal of Neurochemistry, 1990
- Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the ratJournal of Comparative Neurology, 1989